Eltanexor (KPT-8602) is a selective XPO1 inhibitor. It affects MAPK, STAT3, and p53 signaling pathways by binding to XPO1 and blocking nuclear export, effectively inhibiting cancer cell proliferation and promoting apoptosis.
Eltanexor (KPT-8602) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Eltanexor (KPT-8602) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Eltanexor (KPT-8602) Mechanism of Action: XPO1 Inhibition in Hematopoietic Malignant Cell Research
- Eltanexor (KPT-8602) Clinical Trials
- Eltanexor (KPT-8602) Working Concentration | Cell Culture | Treatment
- Eltanexor (KPT-8602) Solubility in DMSO
- Eltanexor (KPT-8602) Stock Solution
- Eltanexor (KPT-8602) Storage
- Eltanexor (KPT-8602) Stability
- Eltanexor (KPT-8602) Combination Database
- Eltanexor (KPT-8602) Molecular Weight
- Eltanexor (KPT-8602) SMILES
- Eltanexor (KPT-8602) CAS Number
- Eltanexor (KPT-8602) Chemical Structure (2D and 3D)
- Eltanexor (KPT-8602) Sigma (BL3H9998F935)? Try a better option.
- Eltanexor (KPT-8602) APExBIO (B8335)? Try a better option.
- Eltanexor (KPT-8602) Cayman (43585)? Try a better option.
- Eltanexor (KPT-8602) MedChemExpress (HY-100423)? Try a better option.
- Eltanexor (KPT-8602) SDS｜MSDS